Sanofi (SNY)
(Delayed Data from NSDQ)
$52.40 USD
-0.70 (-1.32%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $52.41 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Earnings News For SNY
-
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
-
Sanofi: Q2 Earnings Snapshot
-
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
-
Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
-
Sanofi: Q1 Earnings Snapshot
-
Sanofi (SNY) Misses on Q4 Earnings and Sales, Stock Down
-
Sanofi: Q4 Earnings Snapshot
-
Sanofi (SNY) Beats on Q3 Earnings, to Spin-Off Consumer Unit
-
Sanofi: Q3 Earnings Snapshot
-
Sanofi (SNY) Beats on Q2 Earnings, Misses Sales, Stock Down
-
Sanofi: Q2 Earnings Snapshot
-
Sanofi (SNY) Q1 Earnings Beat, Sales Miss, Dupixent Strong
-
Sanofi: Q1 Earnings Snapshot
-
Will Sanofi (SNY) Surpass Estimates This Earnings Season?
-
Sanofi (SNY) Q4 Earnings Miss Estimates, Vaccine Sales Weak
-
Sanofi: Q4 Earnings Snapshot
-
Can Sanofi (SNY) Keep the Beat Streak Alive in Q4 Earnings?
-
Sanofi (SNY), GSK Receive EU Approval for COVID-19 Vaccine
-
Sanofi (SNY) Q3 Earnings Beat, Dupixent, Flu Jabs Push Sales
-
Sanofi: Q3 Earnings Snapshot
-
Sanofi (SNY) to Report Q3 Earnings: What's in the Cards?
-
Sanofi (SNY) Q2 Earnings & Sales Beat, Ups 2022 Growth View
-
Sanofi: Q2 Earnings Snapshot
-
Sanofi (SNY) Q1 Earnings Top, Vaccines Recover, CHC Sales Rise
-
Sanofi (SNY) Q4 Earnings Beat, Vaccines Hurt Sales Growth